Latest Research
Curated selection of the latest peer-reviewed studies and clinical trials in pediatric oncology from leading US institutions.
Featured • Front Public Health
Employment and financial experiences in millennial family caregivers.
Thomas Hebdon MC, Dupree G, Hernandez J et al.
Read full study
Recent Publications
12 articlesJ Blood Med
A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with Severe Congenital Protein C Deficiency (SCPCD).
Koh K, Nogami K, Kakuda H et al.
iScience
LMO1 expression in neuroblastoma cells reprograms tumor-associated macrophages to promote metastasis.
Tan KE, Her ZP, Zhang C et al.
Mol Ther Oncol
The evolving landscape of CAR T cell therapy in children and young adults with B cell acute lymphoblastic leukemia.
Dreyzin A, Gava F, Lamplugh C et al.
Curr Opin Physiol
"Perinatal microbial exposure and the shaping of the early immune system: lessons from experimental models".
Smith P, Whillock A, Schuldt NJ
J Adolesc Young Adult Oncol
Development of a Novel Psychosocial Intervention to Improve Symptom Management for Adolescents and Young Adults with Advanced or Recurrent Cancer.
Dorfman CS, Somers TJ, Arrato NA et al.
Cancer Med
Barriers to Occupational and Physical Therapy Utilization for Children With Cancer.
Swartz MC, Zhang S, Kelly D et al.
BMJ Open
Using flow cytometry for paediatric leukaemia diagnosis in Kenya: a protocol for mixed methods study.
Severance T, Lotodo T, Serem E et al.
Neuro Oncol
Response to "Reporting of outcomes of young children with embryonal CNS tumors after radiotherapy-avoiding strategies: Comments on ACNS0334".
Leary SES, Kang G, Aridgides PD et al.
Neuro Oncol
Targeting tumor-associated macrophages-induced IGF1/PI3K/Zic1 axis triggers SHH medulloblastoma regression and chemosensitization.
Pang YC, Wang C, Qiu JF et al.
Eur J Haematol
Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.
Musallam KM, Cappellini MD, Kattamis A et al.
Acta Neuropathol Commun
LncRNA-HLX-2-7/HLX axis-dependent metabolic reprogramming drives cancer progression in group 3 medulloblastoma.
Katsushima K, Sanada Y, Scott DA et al.
Nat Microbiol
Weaning drives microbiome-mediated epigenetic regulation to shape immune memory in mice.
Yang L, Peery RC, Zhou S et al.